✦ LIBER ✦

Differential effects of the enantiomers of 3-(3-hydroxyphenyl)-N-n-propylpiperidine (3-PPP) at dopamine receptors sites

✍ Scribed by Susan W. Koch; B.Kenneth Koe; Nicholas G. Bacopoulos

Book ID: 115877862
Publisher: Elsevier Science
Year: 1983
Tongue: English
Weight: 334 KB
Volume: 92
Category: Article
ISSN: 0014-2999
DOI: 10.1016/0014-2999(83)90299-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lack of effect of intranigral administra

Lack of effect of intranigral administration of a dopamine analogue, (±)-3-(3-hydroxyphenyl)-N,n-propylpiperidine [(±)-3-PPP], on nigrostriatal dopamine neurones

✍ Kelly, E.; Jenner, P.; Marsden, C.D. 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 334 KB

Involvement of catechol-O-methyl transfe

Involvement of catechol-O-methyl transferase in the metabolism of the putative dopamine autoreceptor agonist 3-PPP(3-(3-hydroxyphenyl)-N-n-propylpiperidine)

✍ Noirin Nic A Bhaird; Christopher J. Fowler; Olov Thorberg; Keith F. Tipton 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 292 KB

Motor effects of the partial dopamine ag

Motor effects of the partial dopamine agonist (−)-3-(3-hydroxyphenyl)-N-n-propylpiperidine (preclamol) in Parkinson's disease

✍ L. Verhagen Metman; V. H. Sethy; J. R. Roberts; D. Bravi; J. I. Hoff; M. M. Mour 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 480 KB

## Abstract The motor effects of the partial dopamine agonist (–)‐3‐(3‐hydroxyphenyl)‐N‐n‐propylpiperidine [(–)‐3‐PPP, preclamol] were evaluated in nine patients with Parkinson's disease using a double‐blind, placebocontrolled design. (–)‐3‐PPP monotherapy had an antiparkinsonian effect in five of

Enantiomers of 3-(3,4-dihydroxyphenyl)-

Enantiomers of 3-(3,4-dihydroxyphenyl)- and 3-(3-hydroxyphenyl)-N-n-propylpiperidine: central pre- and postsynaptic dopaminergic effects and pharmacokinetics

✍ Rollema, Hans; Mastebroek, Dora; Wikstroem, Haakan; Svensson, Kjell; Carlsson, A 📂 Article 📅 1986 🏛 American Chemical Society 🌐 English ⚖ 991 KB

Antipsychotic Properties of the Partial

Antipsychotic Properties of the Partial Dopamine Agonist (−)-3-(3-Hydroxyphenyl)-N-n-Propylpiperidine (Preclamol) in Schizophrenia

✍ Adrienne C Lahti; Martin A Weiler; Patricia K Corey; Robert A Lahti; Arvid Carls 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 203 KB

Behavioral and biochemical effects of su

Behavioral and biochemical effects of subchronic treatment with (−)3-(3-hydroxyphenyl)-N-n-propylpiperidine in the rat: Dopamine receptor sensitivity and tolerance

✍ S. Ahlenius; V. Hillegaart; O. Magnusson; J. Lundström 📂 Article 📅 1984 🏛 Springer 🌐 English ⚖ 471 KB